Saturday 17 October 2026
Export SGRY’s income statement to Excel — free account
Surgery Partners, Inc.
SGRY Healthcare Medical Care Facilities
Surgery Partners, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 6.24% from fiscal 2024. In the quarter to June 2026, revenue grew 2.75%, EPS fell 500.0%, free cash flow fell 60.6% and total debt rose 4.92%, each against the same quarter a year earlier. Revenue growth for ten consecutive years; insiders bought in the last twelve months.
14.64
0.13
−0.88%
Follow SGRY
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 81.58 |
Piotroski F-Score |
4 | 5 | 6 | 7 | 7 | 3 | 3 | 4 | 3 | 6 |
P/S ratio |
0.59 | 0.86 | 1.45 | 0.95 | 1.74 | 0.76 | 0.41 | 0.27 | 0.48 | 0.65 |
Altman Z-Score |
0.75 | 0.83 | 1.14 | 0.93 | 1.06 | 0.61 | 0.59 | 0.52 | 0.58 | 0.92 |
Altman Z″-Score (non-manufacturers) |
1.11 | 1.14 | 1.25 | 1.33 | 1.01 | 0.61 | 0.69 | 0.76 | 1.17 | 0.82 |
P/FCF ratio |
8.12 | 12.58 | 17.21 | 26.55 | 108.97 | 5.39 | 10.29 | 3.79 | 7.07 | 8.64 |
Beneish M-Score |
(2.52) | (2.55) | (2.55) | (2.47) | (2.39) | (2.45) | (2.49) | (2.61) | (2.10) | (2.31) |
P/Operating CF |
19.01 | 23.97 | 63.47 | 335.88 | 196.36 | 158.99 | 29.77 | 10.33 | 11.86 | 22.99 |
Dividend Safety Score |
4 | — | — | — | — | — | — | — | — | — |
P/B ratio |
0.63 | 0.84 | 1.31 | 0.82 | 1.96 | 1.60 | 0.77 | 0.43 | 0.48 | 2.29 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
1.64 | 1.85 | 2.39 | 1.87 | 2.88 | 2.13 | 1.77 | 1.47 | 1.98 | 1.85 |
EV/EBITDA |
9.22 | 11.08 | 14.23 | 10.07 | 15.56 | 13.70 | 10.06 | 16.95 | 12.28 | 8.79 |
EV/Operating CF |
19.79 | 19.23 | 22.30 | 29.96 | 73.68 | 16.01 | 25.05 | 18.07 | 22.00 | 16.90 |
EV/FCF |
22.42 | 27.18 | 28.39 | 52.22 | 180.77 | 15.06 | 44.14 | 21.07 | 29.13 | 24.58 |
Quick Ratio |
1.37 | 1.36 | 1.32 | 1.50 | 1.53 | 1.26 | 1.05 | 1.41 | 1.53 | 1.55 |
Current Ratio |
1.87 | 1.79 | 1.71 | 1.87 | 1.76 | 1.44 | 1.32 | 1.68 | 1.86 | 1.94 |
Net Debt/EBITDA |
5.88 | 5.95 | 5.60 | 4.95 | 6.18 | 8.80 | 7.71 | 13.90 | 9.30 | 5.70 |
Debt/Assets |
45.60% | 42.72% | 40.36% | 39.24% | 48.04% | 52.77% | 51.42% | 49.75% | 47.36% | 62.57% |
Debt/Equity |
1.18 | 1.05 | 0.91 | 0.89 | 1.49 | 2.17 | 1.87 | 1.60 | 1.31 | 4.44 |
Asset Turnover |
0.41 | 0.42 | 0.40 | 0.40 | 0.39 | 0.36 | 0.38 | 0.38 | 0.39 | 0.52 |
Operating CF/Net income |
(3.52) | (1.79) | (24.69) | (2.91) | (1.07) | (1.59) | (1.17) | (0.61) | (1.53) | 13.25 |
Capex/Depreciation |
(0.18) | (0.58) | (0.53) | (0.59) | (0.52) | 0.16 | (0.73) | (0.31) | (0.57) | (0.99) |
Interest Coverage |
1.51 | 1.83 | 1.77 | 1.52 | 1.42 | 0.96 | 1.38 | 0.59 | 1.40 | 2.00 |
| (2.46%) | (5.40%) | (0.40%) | (2.22%) | (5.69%) | (16.68%) | (10.61%) | (19.55%) | (9.52%) | 3.04% | |
| (0.97%) | (2.28%) | (0.18%) | (0.85%) | (1.41%) | (2.98%) | (2.28%) | (5.12%) | (2.28%) | 0.43% | |
ROIC |
3.69% | 3.46% | 3.65% | 4.09% | 4.18% | 2.97% | 3.81% | 1.35% | 2.69% | 7.24% |
Return on Tangible Assets |
(4.61%) | (10.62%) | (0.89%) | (4.19%) | (7.82%) | (19.71%) | (16.98%) | (35.79%) | (12.01%) | 2.49% |
Average Days of Receivables |
66.43 | 67.87 | 66.05 | 65.59 | 70.57 | 75.00 | 65.15 | 63.38 | 78.38 | 70.29 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
3.57% | 4.45% | 4.41% | 4.02% | 2.97% | 2.74% | 4.84% | 5.28% | 5.67% | 5.26% |
Intangible Assets out of Total Assets |
0.64 | 0.65 | 0.64 | 0.63 | 0.65 | 0.65 | 0.69 | 0.74 | 0.74 | 0.70 |
Share Based Compensation of Revenue |
0.45% | 1.07% | 0.65% | 0.72% | 0.78% | 0.71% | 0.56% | 0.52% | 0.42% | 0.18% |
Graham Net Nets |
(1.95) | (1.34) | (0.74) | (1.17) | (0.83) | (2.33) | (4.12) | (5.59) | (3.71) | (2.17) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.38 |
Earnings Yield |
(4.01%) | (6.28%) | (0.32%) | (2.21%) | (2.32%) | (10.96%) | (14.50%) | (50.66%) | (12.28%) | 1.23% |
Free Cash Flow Yield |
12.32% | 7.95% | 5.81% | 3.77% | 0.92% | 18.55% | 9.72% | 26.37% | 14.15% | 11.57% |
Revenue per Share |
26.01 | 24.69 | 21.84 | 27.62 | 30.72 | 38.14 | 37.93 | 36.88 | 27.76 | 23.85 |
Operating CF per Share |
2.16 | 2.38 | 2.34 | 1.73 | 1.20 | 5.06 | 2.68 | 3.01 | 2.50 | 2.61 |
Capex per Share |
(0.25) | (0.70) | (0.50) | (0.74) | (0.71) | 0.32 | (1.16) | (0.43) | (0.61) | (0.81) |
Free Cash Flow per Share |
1.90 | 1.68 | 1.84 | 0.99 | 0.49 | 5.38 | 1.52 | 2.58 | 1.89 | 1.79 |
Cash per Share |
1.89 | 2.14 | 1.56 | 3.08 | 5.38 | 6.52 | 1.92 | 3.84 | 3.62 | 1.45 |
Shareholders Equity per Share |
24.62 | 25.34 | 24.16 | 31.98 | 27.19 | 26.99 | 28.55 | 30.36 | 34.51 | 6.76 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
24.62 | 25.34 | 24.16 | 31.98 | 27.19 | 26.99 | 28.55 | 30.36 | 34.51 | 6.76 |
Free Cash Flow |
242.10 | 212.30 | 230.80 | 91.10 | 35.50 | 262.50 | 73.50 | 124.00 | 91.30 | 86.13 |
Working Capital |
535.20 | 495.00 | 372.00 | 427.60 | 409.30 | 244.70 | 127.40 | 239.00 | 260.22 | 175.23 |
Capital Expenditures |
(32.20) | (87.80) | (63.00) | (67.70) | (51.60) | 15.60 | (56.00) | (20.60) | (29.60) | (39.11) |
Net Current Asset Value |
(3,837.70) | (3,574.20) | (2,947.20) | (2,820.20) | (3,201.90) | (3,295.10) | (3,115.00) | (2,629.80) | (2,392.13) | (1,618.33) |
EV/EBIT |
13.16 | 15.67 | 19.15 | 13.30 | 20.47 | 20.40 | 13.18 | 30.13 | 16.15 | 10.52 |
Capex to Sales |
0.01 | 0.03 | 0.02 | 0.03 | 0.02 | (0.01) | 0.03 | 0.01 | 0.02 | 0.03 |
Price to Operating Income |
5.05 | 7.65 | 12.11 | 7.01 | 12.80 | 7.73 | 3.21 | 6.04 | 4.07 | 3.79 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.15 | 0.14 | 0.12 | 0.13 | 0.16 | 0.17 | 0.15 | 0.16 | 0.13 | 0.19 |
Cash ROIC |
3.42% | 3.11% | 3.84% | 1.56% | 0.67% | 5.84% | 1.81% | 3.12% | 2.26% | 4.69% |
Accounts Receivable Turnover |
5.60 | 5.79 | 5.76 | 5.73 | 5.48 | 5.25 | 5.77 | 5.95 | 5.27 | 5.74 |
Accounts Payable Turnover |
12.19 | 12.45 | 12.96 | 14.21 | 15.40 | 15.04 | 15.64 | 16.21 | 15.08 | 17.27 |
Inventory Turnover |
27.50 | 28.96 | 28.59 | 29.65 | 29.51 | 28.83 | 31.38 | 30.82 | 27.50 | 30.21 |
Average Days of Payables |
29.95 | 32.16 | 29.92 | 28.17 | 26.30 | 24.71 | 25.08 | 22.33 | 30.50 | 22.12 |
Days of Inventory on Hand |
13.86 | 13.62 | 13.10 | 13.27 | 12.86 | 13.91 | 12.01 | 11.64 | 16.18 | 12.79 |
Average Receivables |
590.65 | 537.75 | 476.35 | 443.25 | 406.20 | 354.55 | 317.25 | 297.81 | 254.31 | 199.71 |
Average Payables |
208.70 | 190.25 | 161.70 | 138.25 | 112.55 | 98.45 | 90.00 | 84.01 | 67.24 | 47.55 |
Average Inventory |
92.50 | 81.80 | 73.30 | 66.25 | 58.75 | 51.35 | 44.85 | 44.18 | 36.86 | 27.18 |
Average Assets |
8,004.85 | 7,383.35 | 6,779.40 | 6,399.85 | 5,765.40 | 5,216.05 | 4,847.60 | 4,649.54 | 3,463.87 | 2,204.70 |
Average Common Equity |
3,163.85 | 3,115.45 | 2,987.70 | 2,455.25 | 1,425.85 | 932.75 | 1,041.15 | 1,217.76 | 830.64 | 311.30 |
Columns are period end dates